DNA methylation in the pathogenesis of type 2 diabetes

Vitam Horm. 2023:122:147-169. doi: 10.1016/bs.vh.2022.11.002. Epub 2022 Dec 16.

Abstract

Type 2 diabetes (T2D) is a metabolic disease characterized by the development of β-cell dysfunction with hepatic, muscular and adipose tissue insulin resistance. Although the molecular mechanisms leading to its development are not entirely known, investigations of its causes reveal a multifactorial contribution to its development and progression in most cases. In addition, regulatory interactions mediated by epigenetic modifications such as DNA methylation, histone tail modifications and regulatory RNAs have been found to play a significant role in the etiology of T2D. In this chapter, we discuss the role of DNA methylation and its dynamics in the development of the pathological features of T2D.

Keywords: DNA methylation; Epigenetic modifications; Glucose; Insulin resistance; Metabolic diseases; Type 2 diabetes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipose Tissue
  • DNA Methylation*
  • Diabetes Mellitus, Type 2* / genetics
  • Epigenesis, Genetic
  • Humans